Racial disparities exist among the population of individuals who use aspirin as a primary prevention for coronary heart disease (CHD). In 2000-2002, aspirin use among those at an increased risk of CHD was 25% among Caucasians, 14% among African Americans, 12% among Hispanics, and 14% among Chinese. After new guidelines for the use of aspirin